A case series of the rifampin-warfarin drug interaction: focus on practical warfarin management.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 341, doi. 10.1007/s00228-020-03057-x
- By:
- Publication type:
- Article
Works matching IS 00316970 AND DT 2021 AND VI 77 AND IP 3
Results: 17
1
2
Switching from a traditional undergraduate programme in (clinical) pharmacology and therapeutics to a problem-based learning programme.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 421, doi. 10.1007/s00228-020-03027-3
- By:
- Publication type:
- Article
3
Second-generation antipsychotics and pregnancy complications: the impact of confounding by indication.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 439, doi. 10.1007/s00228-020-03025-5
- By:
- Publication type:
- Article
4
Association of FMO3 rs1736557 polymorphism with clopidogrel response in Chinese patients with coronary artery disease.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 359, doi. 10.1007/s00228-020-03024-6
- By:
- Publication type:
- Article
5
Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 389, doi. 10.1007/s00228-020-03020-w
- By:
- Publication type:
- Article
6
The association of GATM polymorphism with statin-induced myopathy: a systematic review and meta-analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 349, doi. 10.1007/s00228-020-03019-3
- By:
- Publication type:
- Article
7
Benefits and adverse effects of ACE inhibitors in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 321, doi. 10.1007/s00228-020-03018-4
- By:
- Publication type:
- Article
8
Tocilizumab for treating COVID-19: a systemic review and meta-analysis of retrospective studies.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 311, doi. 10.1007/s00228-020-03017-5
- By:
- Publication type:
- Article
9
Lipid-lowering medication use and cancer-specific survival among endometrial or lung cancer patients: an Australian nationwide cohort study.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 399, doi. 10.1007/s00228-020-03009-5
- By:
- Publication type:
- Article
10
Impact of histamine type-2 receptor antagonists on the anticancer efficacy of gefitinib in patients with non-small cell lung cancer.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 381, doi. 10.1007/s00228-020-03013-9
- By:
- Publication type:
- Article
11
Potentially inappropriate medication in older psychiatric patients.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 331, doi. 10.1007/s00228-020-03012-w
- By:
- Publication type:
- Article
12
Pharmacokinetic variability of phenobarbital: a systematic review of population pharmacokinetic analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 291, doi. 10.1007/s00228-020-03011-x
- By:
- Publication type:
- Article
13
Associations between plasma hydroxylated metabolite of itraconazole and serum creatinine in patients with a hematopoietic or immune-related disorder.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 369, doi. 10.1007/s00228-020-03010-y
- By:
- Publication type:
- Article
14
Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants—a Swedish, register-based cohort study in atrial fibrillation outpatients.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 409, doi. 10.1007/s00228-020-03015-7
- By:
- Publication type:
- Article
15
Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 435, doi. 10.1007/s00228-020-03008-6
- By:
- Publication type:
- Article
16
Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 275, doi. 10.1007/s00228-020-03005-9
- By:
- Publication type:
- Article
17
Presence of the aldehyde dehydrogenase 2 variant ALDH2*2 considerably increases EC50 of nitroglycerin.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 431, doi. 10.1007/s00228-020-02999-6
- By:
- Publication type:
- Article